Literature DB >> 6362925

Relations between immunoreactive somatomedin C, insulin and T3 patterns during fasting in obese subjects.

A Caufriez, J Golstein, P Lebrun, A Herchuelz, R Furlanetto, G Copinschi.   

Abstract

Plasma glucose, immunoreactive somatomedin-C (Sm-C), GH, insulin (IRI) and T3 were measured daily in 20 obese subjects before and during a 9-day fast. Control levels of Sm-C were normal and exhibited no significant correlation with any of the other parameters investigated. During fasting there were no consistent variations in GH, but significant decreases occurred in blood glucose, IRI, T3 and Sm-C levels. While individual Sm-C patterns varied widely, as a group the fasting Sm-C values showed a positive correlation with the fasting IRI and T3 levels, and with control body weight. These findings suggest that the decrease in Sm-C which occurs during caloric deprivation may be the result of concomitant decreases occurring in T3 and IRI levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6362925     DOI: 10.1111/j.1365-2265.1984.tb00060.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  10 in total

Review 1.  Minor head injury.

Authors:  T F Beattie
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

2.  Reduced levels of growth hormone, insulin-like growth factor-I and binding protein-3 in patients with shunted hydrocephalus.

Authors:  T Löppönen; A L Saukkonen; W Serlo; P Tapanainen; A Ruokonen; M Knip
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

3.  Spontaneous growth hormone and somatomedin-C/insulin-like growth factor-I secretion in obese subjects during puberty.

Authors:  F Minuto; A Barreca; P Del Monte; P Fortini; M Resentini; F Morabito; G Giordano
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

4.  Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity.

Authors:  S E Oleandri; M Maccario; R Rossetto; M Procopio; S Grottoli; E Avogadri; C Gauna; C Ganzaroli; E Ghigo
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

5.  The activity of GH/IGF-I axis in anorexia nervosa and in obesity: a comparison with normal subjects and patients with hypopituitarism or critical illness.

Authors:  L Gianotti; F Broglio; J Ramunni; F Lanfranco; C Gauna; A Benso; M Zanello; E Arvat; E Ghigo
Journal:  Eat Weight Disord       Date:  1998-06       Impact factor: 4.652

6.  Bioactive insulin-like growth factor-I in obesity.

Authors:  J Frystyk; D J Brick; A V Gerweck; A L Utz; K K Miller
Journal:  J Clin Endocrinol Metab       Date:  2009-05-26       Impact factor: 5.958

7.  Concentrations of somatomedin-C and triiodothyronine in patients with thyroid dysfunction and nonthyroidal illnesses.

Authors:  M Välimäki; S L Karonen; T Helenius; A M Suikkari
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

8.  Androgens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion.

Authors:  A L Utz; A Yamamoto; P Sluss; J Breu; K K Miller
Journal:  J Clin Endocrinol Metab       Date:  2008-07-22       Impact factor: 5.958

9.  Osteoclast recruitment and modulation by calcium deficiency, fasting, and calcium supplementation in the rat.

Authors:  K R Wright; P J McMillan
Journal:  Calcif Tissue Int       Date:  1994-01       Impact factor: 4.333

10.  Low level of IGF-1 in obesity may be related to obstructive sleep apnea syndrome.

Authors:  Ahmet Ursavas; Mehmet Karadag; Yesim Ozarda Ilcol; Ilker Ercan; Basak Burgazlioglu; Funda Coskun; R Oktay Gozu
Journal:  Lung       Date:  2007-08-27       Impact factor: 3.777

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.